MANAGEMENT OF MYASTHENIA GRAVIS IN PREGNANCY

Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 3

Abstract

As with several autoimmune diseases, myasthenia gravis (MG) occurs frequently in young women in their childbearing years. The treatment of MG in women therefore poses unique and challenging issues to neurologists, obstetricians, and neonatologists as the safety of both mother and fetus needs to be carefully considered when choosing a therapeutic plan. The severity of generalized weakness and the potential for respiratory insufficiency and myasthenic crises in the mother should dictate how aggressive a treatment plan should be. The potential effects of immunosuppressant medications on the fetus should always be weighed against the risk of myasthenic crises and its potential to endanger both mother and fetus. Successful management of MG during pregnancy and in the postpartum period is possible in many cases but requires collaboration between the obstetrician, the neurologist, and a well-informed patient. The neurologist should be able to counsel women and discuss treatment options and pregnancy risks based on the best current knowledge, so that women will be able to make an informed decision and successfully complete pregnancy.

Authors and Affiliations

Rajaa Majid Abdulateef

Keywords

Related Articles

A REVIEW STUDY OF DRAKASHADI GUTIKA ON AMLAPITTA W.S.R. HYPERACIDITY

Amlapitta is a very common lifestyle disorder in present era which caused by to vitiation of pitta and kapha by Ama. If not treated in timely, signs and symptoms of Amlapitta are very similar to Hyperacidity. It is chara...

TOTAL PHENOLIC AND FLAVONOID CONTENTS AND ANTIOXIDANT ACTIVITY OF LANTANA CAMARA AND CUCURBITA PEPO (SQUASH) EXTRACTS AS WELL AS GC-MS ANALYSIS OF LANTANA CAMARA ESSENTIAL OILS

This study aimed to determine total phenolic and flavonoid contents as well as evaluate antioxidant activity of the defatted methanolic extracts of flowers, leaves, stems and certain fractions (dichloromethane, ethyl ace...

A REVIEW ON ZIKA VIRUS

Zika, is a flavivirus mainly transmitted by mosquitos of Aedes genus, it was discovered in 1947 in Uganda. The World population is facing different health problems from zika virus and it’s vector. A pregnant woman can pa...

HOLISTIC APPROACH OF AYURVEDA IN GERIATRICS: REVIEW ARTICLE

In present era medical science deals exclusively with the problem of ageing and diseases occur due to ageing. Geriatrics is emerging as a main challenging specialty because of ever growing population of aged people all o...

TAXONOMICAL AND MEDICINAL PROPERTIES AS WELL AS ADAPTATIONS OF AVICENNIA MARINA (GREY MANGROVE) AT MACHILIPATNAM SEACOAST, ANDHRA PRADESH, INDIA

Mangroves are specialized ecosystems, known to tolerate high salinity, tidal extremes, and high fluctuations in wind, temperature and muddy anaerobic soil with the development of some adaptive morphological characteristi...

Download PDF file
  • EP ID EP671909
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

Rajaa Majid Abdulateef (2019). MANAGEMENT OF MYASTHENIA GRAVIS IN PREGNANCY. World Journal of Pharmaceutical Research, 8(3), 67-81. https://europub.co.uk./articles/-A-671909